Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury.
McMahon KR, Chui H, Rassekh SR, Schultz KR, Blydt-Hansen TD, Mammen C, Pinsk M, Cuvelier GDE, Carleton BC, Tsuyuki RT, Ross CJD, Devarajan P, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Cockovski V, Palijan A, Zappitelli M. McMahon KR, et al. Among authors: yordanova m. Kidney360. 2021 Nov 3;3(1):37-50. doi: 10.34067/KID.0004802021. eCollection 2022 Jan 27. Kidney360. 2021. PMID: 35368557 Free PMC article.
Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR, Rassekh SR, Schultz KR, Blydt-Hansen T, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Palijan A, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group. McMahon KR, et al. Among authors: yordanova m. JAMA Netw Open. 2020 May 1;3(5):e203639. doi: 10.1001/jamanetworkopen.2020.3639. JAMA Netw Open. 2020. PMID: 32383745 Free PMC article.
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR, Lebel A, Rassekh SR, Schultz KR, Blydt-Hansen TD, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Palijan A, Lee J, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group. McMahon KR, et al. Among authors: yordanova m. Pediatr Nephrol. 2023 May;38(5):1667-1685. doi: 10.1007/s00467-022-05745-5. Epub 2022 Oct 19. Pediatr Nephrol. 2023. PMID: 36260162
Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides.
Chui H, Caldwell J, Yordanova M, Cockovski V, Fredric D, Harel-Sterling M, Haasz M, Al-Ismaili Z, Pizzi M, Ma Q, Devarajan P, Goldstein SL, Zappitelli M. Chui H, et al. Among authors: yordanova m. Biomark Med. 2020 Jul;14(10):879-894. doi: 10.2217/bmm-2019-0419. Epub 2020 Aug 18. Biomark Med. 2020. PMID: 32808826 Free PMC article.
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin.
Chui H, McMahon KR, Rassekh SR, Schultz KR, Blydt-Hansen TD, Mammen C, Pinsk M, Cuvelier GDE, Carleton BC, Tsuyuki RT, Ross CJD, Devarajan P, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Cockovski V, Palijan A, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group. Chui H, et al. Among authors: yordanova m. Pediatr Nephrol. 2024 Jan;39(1):269-282. doi: 10.1007/s00467-023-06007-8. Epub 2023 Jun 26. Pediatr Nephrol. 2024. PMID: 37365422
37 results